10.1155/2013/162750 [DOI] [PMC free article] [PubMed] [Google Scholar] Latella G., Vetuschi A., Sferra R., Catitti V., D'Angelo A., Zanninelli G., et al
Immuno-compromised individuals susceptible to HHV infection are at higher risk for SARS-CoV-2 infection, PASC, are vulnerable to develop virusassociated cancers
Safe at high doses, with the highest dose in a trial of 18 g/day, and the most common side effect is GI upset
doi: 10.3389/fphar.2020.579944 255 Sharifi-RadM.KumarN
In a clinical trial, regular intake of milk kefir by sixty diabetic patients showed a significant decrease in fasting blood glucose and glycated haemoglobin (HbA1C), showing that milk kefir is a promising beverage that can potentially improve glucose regulation of diabetic patients (Ostadrahimi et al., 2015)